Literature DB >> 17940464

Endothelial dysfunction in obesity: etiological role in atherosclerosis.

Melissa R Meyers1, Noyan Gokce.   

Abstract

PURPOSE OF REVIEW: To review studies of vascular endothelial dysfunction in obesity, discuss potential mechanisms of disease, and address the therapeutic effects of weight loss interventions on arterial health. RECENT
FINDINGS: Endothelial dysfunction represents the earliest abnormality in the development of vascular disease, and is pathophysiologically linked to subsequent atherosclerosis progression and cardiovascular disease events. Obesity is closely associated with a number of established cardiovascular risk factors, including diabetes mellitus, insulin resistance, dyslipidemia, and hypertension that are cumulatively damaging to the endothelium. In addition, there is now a growing recognition of non-traditional risk factors as potential modulators of the endothelial phenotype in obesity, including fat tissue production of proatherogenic adipokines, oxidative stress, and chronic inflammation. Clinical studies have demonstrated that even modest weight loss reverses endothelial dysfunction, and the restoration of arterial homeostasis could potentially reduce cardiovascular risk.
SUMMARY: Obesity is associated with altered arterial homeostasis and endothelial dysfunction. Mechanisms of disease are related to a complex interplay of metabolic and inflammatory factors that coordinately improve along with arterial function in response to weight loss interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940464     DOI: 10.1097/MED.0b013e3282be90a8

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  50 in total

Review 1.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

2.  Reduced flow-and acetylcholine-induced dilations in visceral compared to subcutaneous adipose arterioles in human morbid obesity.

Authors:  Ivana Grizelj; Ana Cavka; Jing-Tan Bian; Mary Szczurek; Austin Robinson; Shruti Shinde; Van Nguyen; Carol Braunschweig; Edward Wang; Ines Drenjancevic; Shane A Phillips
Journal:  Microcirculation       Date:  2015-01       Impact factor: 2.628

3.  Inhalation toxicology methods: the generation and characterization of exposure atmospheres and inhalational exposures.

Authors:  Lung-Chi Chen; Morton Lippmann
Journal:  Curr Protoc Toxicol       Date:  2015-02-02

4.  Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.

Authors:  Jing Li; Andreas J Flammer; Ryan J Lennon; Rebecca E Nelson; Rajiv Gulati; Paul A Friedman; Randal J Thomas; Nicole P Sandhu; Qi Hua; Lilach O Lerman; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2012-09-12       Impact factor: 7.616

5.  Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.

Authors:  Changyi Chen; Jun Jiang; Jian-Ming Lü; Hong Chai; Xinwen Wang; Peter H Lin; Qizhi Yao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-30       Impact factor: 4.733

6.  Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.

Authors:  L M Steffen; M Cushman; J M Peacock; S R Heckbert; D R Jacobs; W D Rosamond; A R Folsom
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

7.  Adiposity, but not Obesity, Is Associated With Arterial Stiffness in Young Nulliparous Women.

Authors:  Julie Phillips; Carole A McBride; Erin Morris; Abigail M Crocker; Ira Bernstein
Journal:  Reprod Sci       Date:  2017-09-01       Impact factor: 3.060

8.  Asthma, environmental risk factors, and hypertension among Arab Americans in metro Detroit.

Authors:  Markey Johnson; Jerome Nriagu; Adnan Hammad; Kathryn Savoie; Hikmet Jamil
Journal:  J Immigr Minor Health       Date:  2008-11-08

9.  Exposure to fine particulate matter and acute effects on blood pressure: effect modification by measures of obesity and location.

Authors:  S Kannan; J T Dvonch; A J Schulz; B A Israel; G Mentz; J House; P Max; A G Reyes
Journal:  J Epidemiol Community Health       Date:  2010-01       Impact factor: 3.710

10.  DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.

Authors:  Y Al-Solaiman; A Jesri; W K Mountford; D T Lackland; Y Zhao; B M Egan
Journal:  J Hum Hypertens       Date:  2009-07-23       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.